These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11373761)

  • 1. [Treating the psychological problems first! Patients with depression don't comply with therapy].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():103. PubMed ID: 11373761
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-positive youths.
    Am J Nurs; 2001 Jun; 101(6):19. PubMed ID: 11441755
    [No Abstract]   [Full Text] [Related]  

  • 3. Take HAART: medication adherence in the era of highly active antiretroviral therapy.
    Allardice K
    Aust Nurs J; 2002 Apr; 9(9):19-21. PubMed ID: 12017049
    [No Abstract]   [Full Text] [Related]  

  • 4. Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients.
    Dalessandro M; Conti CM; Gambi F; Falasca K; Doyle R; Conti P; Caciagli F; Fulcheri M; Vecchiet J
    J Clin Psychopharmacol; 2007 Feb; 27(1):58-61. PubMed ID: 17224714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence in antiretroviral therapy: a review of qualitative studies.
    Vervoort SC; Borleffs JC; Hoepelman AI; Grypdonck MH
    AIDS; 2007 Jan; 21(3):271-81. PubMed ID: 17255734
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing efficacy and tolerability in today's HAART.
    Pozniak A
    AIDS Read; 2003 Sep; ():S4-8. PubMed ID: 14601553
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV therapeutics in children and adults and their side effects.
    Laurence J
    AIDS Read; 2004 Jan; 14(1):6-7. PubMed ID: 14959697
    [No Abstract]   [Full Text] [Related]  

  • 8. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
    Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
    Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.
    Stone VE
    Clin Infect Dis; 2001 Sep; 33(6):865-72. PubMed ID: 11512092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression, adherence to HAART, and survival.
    Perry S; Karasic D
    Focus; 2002 Aug; 17(9):5-6. PubMed ID: 12243133
    [No Abstract]   [Full Text] [Related]  

  • 11. Depression and HIV risk taking.
    Rogers G; Curry M
    Clin Infect Dis; 2008 Apr; 46(8):1321; author reply 1321-2. PubMed ID: 18444876
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of psychiatric disorders in patients infected with human immunodeficiency virus.
    Angelino AF; Treisman GJ
    Clin Infect Dis; 2001 Sep; 33(6):847-56. PubMed ID: 11512090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression & HIV: assessment and treatment.
    Elliott A
    STEP Perspect; 1997; 9(1):1-5. PubMed ID: 11364269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do subjectively-constructed meanings ascribed to anti-HIV treatments affect treatment-adherent practice?
    Wong WK; Ussher J
    Qual Health Res; 2008 Apr; 18(4):458-68. PubMed ID: 18354045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of depression in predicting antiretroviral adherence in Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: commentary on Jayne Byakika-Tusiime et al. 2009.
    Nakimuli-Mpungu E; Musisi S
    AIDS Behav; 2009 Oct; 13(5):969-72. PubMed ID: 19662522
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
    Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
    Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.
    Ammassari A; Antinori A; Aloisi MS; Trotta MP; Murri R; Bartoli L; Monforte AD; Wu AW; Starace F
    Psychosomatics; 2004; 45(5):394-402. PubMed ID: 15345784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.